Cogent Biosciences, Inc. COGT Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s cash ratio?
- Cogent Biosciences, Inc. (COGT) reported cash ratio of 4.2× in Q1 2026.
- How has Cogent Biosciences, Inc.'s cash ratio changed year-over-year?
- Cogent Biosciences, Inc.'s cash ratio increased by 62.8% year-over-year, from 2.6× to 4.2×.
- What is the long-term trend for Cogent Biosciences, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s cash ratio has grown at a -23.4% compound annual growth rate (CAGR), from 18.5× to 4.9×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.